Maduramicin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameMaduramicin
Drug Alias NameMaduramicin ammoniumCL-273703CL-259971
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionCell membrane permeability enhancers
TargetsUpdating
Therapy Area/IndicationsCryptosporidiosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Holdings LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Holdings LLC
Active IndicationsN/A
Inactive IndicationsCryptosporidiosis

Other Information

ATC CodeN/A
Related LinksN/A